Authors:
Pandolfino, MC
Labarriere, N
Tessier, MH
Cassidanius, A
Bercegeay, S
Lemarre, P
Dehaut, F
Dreno, B
Jotereau, F
Citation: Mc. Pandolfino et al., High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement, CANCER IMMU, 50(3), 2001, pp. 134-140
Authors:
Fonteneau, JF
Larsson, M
Somersan, S
Sanders, C
Munz, C
Kwok, WW
Bhardwaj, N
Jotereau, F
Citation: Jf. Fonteneau et al., Generation of high quantities of viral and tumor-specific human CD4+and CD8+T-cell clones using peptide pulsed mature dendritic cells, J IMMUNOL M, 258(1-2), 2001, pp. 111-126
Authors:
Benlalam, H
Labarriere, N
Linard, B
Derre, L
Diez, E
Pandolfino, MC
Bonneville, M
Jotereau, F
Citation: H. Benlalam et al., Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy, EUR J IMMUN, 31(7), 2001, pp. 2007-2015
Authors:
Gervois, N
Labarriere, N
Le Guiner, S
Pandolfino, MC
Fonteneau, JF
Guilloux, Y
Diez, E
Dreno, B
Jotereau, F
Citation: N. Gervois et al., High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells, CLIN CANC R, 6(4), 2000, pp. 1459-1467
Authors:
Moreau-Aubry, A
Le Guiner, S
Labarriere, N
Gesnel, MC
Jotereau, F
Breathnach, R
Citation: A. Moreau-aubry et al., A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma, J EXP MED, 191(9), 2000, pp. 1617-1623
Authors:
Pellat-Deceunynck, C
Mellerin, MP
Labarriere, N
Jego, G
Moreau-Aubry, A
Harousseau, JL
Jotereau, F
Bataille, R
Citation: C. Pellat-deceunynck et al., The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressedby human myeloma cells, EUR J IMMUN, 30(3), 2000, pp. 803-809
Authors:
Valmori, D
Fonteneau, JF
Valitutti, S
Gervois, N
Dunbar, R
Lienard, D
Rimoldi, D
Cerundolo, V
Jotereau, F
Cerottini, JC
Speiser, DE
Romero, P
Citation: D. Valmori et al., Optimal activation of tumor-reactive T cells by selected antigenic peptideanalogues, INT IMMUNOL, 11(12), 1999, pp. 1971-1979
Authors:
Ibisch, C
Gallot, G
Vivien, R
Diez, E
Jotereau, F
Garand, R
Vie, H
Citation: C. Ibisch et al., Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation, BONE MAR TR, 23(11), 1999, pp. 1153-1159
Authors:
Valmori, D
Gervois, N
Rimoldi, D
Fonteneau, JF
Bonelo, A
Lienard, D
Rivoltini, L
Jotereau, F
Cerottini, JC
Romero, P
Citation: D. Valmori et al., Diversity of the fine specificity displayed by HLA-A0201-restricted CTL specific for the immunodominant Melan-A/MART-1. (vol 161, pg 6956, 1998), J IMMUNOL, 163(2), 1999, pp. 1093-1093
Authors:
Choudhary, A
Kurt, RA
Goret, F
Moreau, A
Diez, E
Urba, WJ
Jotereau, F
Pourcel, C
Citation: A. Choudhary et al., Mutated cytochrome b as a determinant of a new monoclonal antibody (H8.98)on renal carcinoma cell lines recognized by a V gamma 3V delta 1(+) T-cellclone, INT J CANC, 82(4), 1999, pp. 562-568
Authors:
Valmori, D
Gervois, N
Rimoldi, D
Fonteneau, JF
Bonelo, A
Lienard, D
Rivoltini, L
Jotereau, F
Cerottini, JC
Romero, P
Citation: D. Valmori et al., Diversity of the fine specificity displayed by HLA-A0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide, J IMMUNOL, 161(12), 1998, pp. 6956-6962